HLHS Cause to Cure

Hypoplastic Left Heart Syndrome Program from Mayo Clinic

Share this:

May 30, 2013 · Leave a Reply

Stem Cell Based Clinical Trial for HLHS

By jthebiay @jthebiay

The Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome at Mayo Clinic takes another step toward  its goal of delaying or preventing heart transplant for people affected with Hypoplastic Left Heart Syndrome, with the announcement of a stem cell-based clinical trial for HLHS.  The clinical trial aims to determine how stem cells derived from autologous umbilical cord blood, and then delivered into the muscle of the right side of the heart at the time of the Glenn procedure, can help children with HLHS.

Dr Harold Burkhart, pediatric cardiac surgeon at Mayo Clinic, discusses the trial in the video below.

------------------------------------------------------------------------------------------------------------------------------------
The Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS) is a collaborative network of specialists bonded by the vision of delaying or preventing heart failure for individuals affected by congenital heart defects including HLHS. The specialized team is addressing the various aspects of these defects by using research and clinical strategies ranging from basic science to diagnostic imaging to regenerative therapies.

Tags: Dr. Harold Burkhart, Dr. Tim Nelson, Glenn Procedure, HLHS, HLHS surgeries, Stem cell therapies, Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome, mayo clinic

Please login or become a member to post a comment.

Contact Us · Privacy Policy